Using TropoCells(R) Autologous Platelet-Rich Fibrin (PRF) to Treat Chronic Non-Healing Wounds

Platelet-based therapies have been used to treat bony and soft tissue effects for more than 30 years. Tropocells® Autologous Platelet-Rich Fibrin (PRF) is being used to treat chronic, non-healing wounds, of a variety of types. This will help determine the safety and effective use of PRF in the treatment of soft tissue defects.

NCT Number	NCT07318792
Lead Sponsor	Estar Medical dba Medical Technologies, LTD Collaborators: Global Clinical Research Institute
Conditions	Wound Chronic Draining, Wound Closure
Enrollment	16 participants
Start Date	2026-01-01
Primary Completion	2026-09-15 (estimated)
Study Completion	2026-12 (estimated)
Updated on ClinicalTrials.gov	2026-01-06